Experience. Results.
(Calls answered 24/7)

June, 2016

Ten years on breast cancer drug may be better

June 6, 2016

A study released Sunday showed that staying on hormone therapy for 10 years reduces the risk of a recurrence of breast cancer. Typically the drug, letrozole, is given for only five years sometimes after a course of another hormone therapy tamoxifen.  While many women with early-stage breast cancer live for Read More

DISCLAIMER: An attorney-client relationship with us cannot be formed by transmission or receipt of the information on this Website and any information you send in an e-mail message to this website will not make you a client. We reserve the right to decline any representation for any reason. This Website is for informational purposes only and is not intended to provide legal advice. You should not act or rely on any information in this Website without seeking the advice of a lawyer